Accumulation of protein-rich interstitial fluid from impaired lymphatic drainage — non-pitting, often unilateral, with positive Stemmer sign.
Also known as: lymphedema, primary lymphedema, secondary lymphedema, filariasis
Overview
Chronic, progressive accumulation of protein-rich interstitial fluid resulting from impaired lymphatic transport. Primary lymphedema arises from congenital or hereditary lymphatic dysplasia (Milroy disease, Meige disease, lymphedema-distichiasis). Secondary lymphedema results from acquired damage or obstruction — surgery, radiation, infection, trauma, or malignancy.
Epidemiology
Globally, the most common cause is lymphatic filariasis (Wuchereria bancrofti, Brugia malayi) affecting >100 million people in tropical regions. In high-income countries, the most common cause is breast cancer treatment, with lymphedema developing in ~20-30% of patients undergoing axillary lymph node dissection and ~5-10% after sentinel node biopsy. Pelvic malignancies (cervical, prostate, vulvar) and melanoma are other notable causes.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Lymphedema outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Family history of primary lymphedema (Milroy disease, FOXC2 mutation in lymphedema-distichiasis)
Tumor compression or invasion of lymphatic channels
Pathophysiology
Impaired lymphatic drainage allows protein-rich interstitial fluid to accumulate. The high protein content draws additional water osmotically, and over time triggers chronic inflammation, fibroblast proliferation, and subcutaneous adipose deposition. The result is progressive, non-pitting, fibrotic limb enlargement that, unlike simple edema, does not resolve with elevation alone. Repeated cellulitis episodes accelerate fibrosis and further compromise residual lymphatic flow, creating a vicious cycle.
Clinical presentation
Symptoms
Insidious, progressive limb swelling — often beginning distally and progressing proximally
Heaviness, fullness, or tightness; subtle initially and often noticed first with rings, watches, or shoes that no longer fit
Reduced range of motion of affected joints as fibrosis progresses
Recurrent episodes of cellulitis or lymphangitis
In late stages: gross deformity (elephantiasis)
Signs / physical exam
Asymmetric (or symmetric in primary) limb enlargement
Positive Stemmer sign: inability to pinch up a fold of skin at the base of the second toe — pathognomonic of lymphedema
Non-pitting edema in chronic stages (early-stage lymphedema may pit before fibrotic changes develop)
Skin thickening, hyperkeratosis, peau d'orange appearance, and verrucous changes in advanced disease
Lymphangitic streaking and tenderness during episodes of cellulitis
Lymphorrhea — leakage of clear lymph from skin breaks in advanced disease
Classic findings
Positive Stemmer sign with non-pitting edema of the foot and dorsum, sparing of the ankle proximally early, and history of axillary or pelvic lymph node intervention or radiation.
Differential diagnosis
Chronic venous insufficiency — Pitting (early), hemosiderin pigmentation, varicose veins, ulcers over medial malleolus, improves with elevation; toes are usually spared (vs lymphedema, which involves toes/dorsum)
Distinguishing lymphedema from venous insufficiency and lipedema — high-yield comparison.
Treatment
First-line
Complete decongestive therapy (CDT) — the cornerstone of conservative management: (1) manual lymphatic drainage massage, (2) multilayer short-stretch compression bandaging followed by daily compression garments (20-40 mmHg, custom-fitted), (3) skin care to prevent infection, and (4) decongestive exercise
Lifelong compression garments to maintain the gains from intensive CDT
Prompt treatment of cellulitis with antistreptococcal antibiotics (penicillin V, amoxicillin, or cephalexin; clindamycin if penicillin-allergic); consider antibiotic prophylaxis (penicillin G benzathine monthly, or oral penicillin V daily) for patients with ≥2 cellulitis episodes per year
Meticulous skin care: moisturization, avoiding cuts, insect bites, sunburn, IV lines, blood pressure cuffs, and venipuncture on the affected limb
Pneumatic compression devices as adjunct in selected patients
Surgical options for refractory disease at experienced centers: lymphovenous anastomosis (LVA), vascularized lymph node transfer (VLNT), liposuction (for late-stage fatty deposition), or debulking procedures (Charles procedure) reserved for elephantiasis
Lymphatic filariasis: diethylcarbamazine ± ivermectin and albendazole; mass drug administration is the public health backbone of elimination programs
Diuretics are NOT effective and may worsen lymphedema by drawing intravascular volume; avoid as primary therapy
Complications
Recurrent cellulitis and erysipelas — accelerates fibrosis and worsens lymphedema
Lymphangitis with sepsis
Functional impairment and disability
Psychological distress, social isolation, body image issues
Stewart-Treves syndrome: rare cutaneous angiosarcoma arising in chronic lymphedema (classically post-mastectomy); presents as a violaceous nodule in the lymphedematous limb
Lymphorrhea, ulceration, secondary fungal infection of skin folds
PANCE pearls
Stemmer sign (inability to pinch a skin fold at the base of the second toe) is pathognomonic of lymphedema and absent in lipedema or venous insufficiency.
Lipedema spares the feet ('cuff sign' at the ankle), is bilateral and symmetric, affects only women, and lacks Stemmer sign — important distinction.
Diuretics have NO role in primary management of lymphedema and may cause harm.
Avoid IV lines, blood pressure cuffs, venipuncture, and other trauma on the at-risk or affected limb (especially in post-axillary dissection patients).
Stewart-Treves syndrome: violaceous nodule in chronic lymphedema = angiosarcoma until proven otherwise; biopsy any suspicious lesion.
References
ISL 2020 — International Society of Lymphology Consensus Document: The Diagnosis and Treatment of Peripheral Lymphedema (Executive Committee, Lymphology 2020)
NLN — National Lymphedema Network Position Papers (multiple)
WHO — Lymphatic Filariasis: Managing Morbidity and Preventing Disability (World Health Organization 2021)
Cochrane Review — Compression bandages and stockings for lymphoedema (Badger et al., Cochrane Database)
Practice Cardiovascular questions on FirstPassPA
Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.